We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
48 hedge funds and large institutions have $24.1M invested in Atara Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 21 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
296% more call options, than puts
Call options by funds: $265K | Put options by funds: $67K
54.61% more ownership
Funds ownership: 3.27% → 57.88% (+55%)
41% less funds holding
Funds holding: 82 → 48 (-34)
48% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 21
58% less capital invested
Capital invested by funds: $57.9M → $24.1M (-$33.8M)
72% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 47
Holders
48
Holders Change
-34
Holders Change %
-41.46%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
11
Reduced
21
Closed
47
Calls
$265K
Puts
$67K
Net Calls
+$198K
Net Calls Change
+$204K
Top Buyers
| 1 |
CC
Centiva Capital
New York
|
+$2.11M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.54M |
| 3 |
Millennium Management
New York
|
+$1.54M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$1.23M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$546K |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.44M |
| 2 |
BlackRock
New York
|
-$3.19M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.35M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.28M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.16M |
